Healthcare & Life Sciences Law in BigLaw

Healthcare is roughly one-fifth of the U.S. economy. It is also one of the most heavily regulated sectors, with overlapping federal and state rules governing everything from drug approval to hospital billing to physician compensation. That combination of size and complexity means enormous demand for legal work — and BigLaw firms have built substantial practices to meet it.

What the Work Actually Looks Like

Healthcare and life sciences law in BigLaw is not one thing. It spans several distinct workstreams:

FDA Regulatory. If a pharmaceutical or medical device company wants to bring a product to market, it needs to navigate FDA approval. Lawyers help with clinical trial design, Investigational New Drug applications, New Drug Applications, 510(k) clearances for devices, and post-approval compliance. As a junior associate, you might draft regulatory submissions, analyze FDA guidance documents, or advise on labeling and promotional review.

Healthcare M&A. Hospitals merge. Physician practices get acquired by private equity. Pharmaceutical companies buy biotech startups for their drug pipelines. Healthcare M&A involves all the standard deal mechanics — due diligence, purchase agreements, financing — plus a layer of regulatory complexity that does not exist in other sectors. You need to address Stark Law and Anti-Kickback Statute compliance, state licensure requirements, certificate-of-need laws, and sometimes CFIUS review for foreign acquirers.

Healthcare Compliance. The False Claims Act generates billions in whistleblower settlements every year, and most of them involve healthcare companies. Compliance work means helping hospitals, pharmaceutical companies, and device manufacturers build programs that prevent fraud and abuse — and defending them when the government comes knocking. This includes internal investigations, voluntary disclosures, and negotiating corporate integrity agreements.

Life Sciences Licensing and Collaboration. When a pharmaceutical company licenses a drug candidate from a biotech startup, or two companies collaborate on clinical development, the deal structure is highly specialized. You draft and negotiate license agreements, co-development agreements, supply agreements, and commercialization arrangements. The economics involve milestone payments, royalty structures, and intellectual property rights that require understanding both the science and the business.

Healthcare Litigation and Enforcement. DOJ and state AG investigations into pharmaceutical pricing, kickback schemes, off-label marketing, and billing fraud. This is high-stakes defense work with potential criminal exposure.

Which Firms Lead

Ropes & Gray is widely considered the top firm for healthcare and life sciences, with deep bench strength in PE-backed healthcare deals, FDA regulatory, and compliance. Sidley Austin has a massive healthcare regulatory practice in DC and Chicago. King & Spalding is strong in healthcare litigation and False Claims Act defense.

Covington & Burling dominates FDA regulatory work from its DC base. Goodwin has a substantial life sciences practice focused on biotech and pharma transactions. McDermott Will & Emery is one of the few firms where healthcare is the single largest practice area.

Why This Area Is Growing

Three trends are driving demand. First, healthcare M&A is booming — private equity firms have poured hundreds of billions into healthcare over the past decade, and each deal needs legal support. Second, regulatory enforcement is increasing, creating defense work. Third, the life sciences sector is producing more drugs, devices, and therapies than ever, each requiring regulatory navigation.

The Inflation Reduction Act's drug pricing provisions have created an entirely new compliance workstream for pharmaceutical companies. AI in healthcare is generating novel regulatory questions. Gene therapy and cell therapy are pushing FDA into new territory. All of this means work.

Who Should Consider This

You do not need a science background, though it helps for FDA regulatory and life sciences licensing work. What you need is comfort with complex regulatory frameworks and a genuine interest in how the healthcare industry operates.

If you find the intersection of business, regulation, and science interesting — or if you want a practice area with strong exit options into in-house roles at pharmaceutical companies, hospitals, and health systems — healthcare and life sciences is one of the best-positioned practices in BigLaw right now.